About cSy74Dc4

This author has not yet filled in any details.
So far cSy74Dc4 has created 85 blog entries.

10.5 million investments for the research in the biomedical sector

2020-01-14T16:22:55+01:00

10.5 million investments for the research in the biomedical sector January 2, 2017 An investment of almost 15 million euros to develop the world's first linear proton accelerator in the upcoming years, which will be produced by Newco [...]

10.5 million investments for the research in the biomedical sector2020-01-14T16:22:55+01:00

Itel in Brussels

2020-01-14T09:59:16+01:00

Itel in Brussels December 1, 2016 By invitation of the Apulia Region, the company of Ruvo di Puglia took part as example of industrial excellence in the roadshow "Global opportunities in Apulia's biotechnology sector” At the invitation of [...]

Itel in Brussels2020-01-14T09:59:16+01:00

Arabs take lessons from Itel’s nuclear medicine

2020-01-15T17:45:10+01:00

Arabs take lessons from Itel's nuclear medicine November 6, 2016 A delegation from the University of Jeddah came to visit "Ospedali Riuniti" of Foggia where, thanks to the recent agreement deal with Itel, was equipped with a Pet [...]

Arabs take lessons from Itel’s nuclear medicine2020-01-15T17:45:10+01:00

Second production line and four new molecules for Itelpharma

2020-01-15T17:41:32+01:00

Second production line and four new molecules for Itelpharma October 31, 2016 They will provide to diagnose neurogenerative diseases. President Diaferia: "It gives me joy to see how many professional talents are growing in and with our company" [...]

Second production line and four new molecules for Itelpharma2020-01-15T17:41:32+01:00

In Foggia, a new weapon against cancer

2020-01-15T17:45:24+01:00

In Foggia, a new weapon against cancer August 1, 2016 It is a Pet / Tac with a radiotracer that allows its precise and accurate identification. Equipment, materials and personnel will be provided by Itel Ospedali Riuniti of [...]

In Foggia, a new weapon against cancer2020-01-15T17:45:24+01:00
Go to Top